Regen BioPharma Inc Pref Share RGBPP
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.10
- Bid/Ask
- $0.00 / $0.00
- Shares Outstanding
- —
- Market Cap
- $39,280.23
- Volume/Avg
- 2,295 / 334,903
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Regen BioPharma Inc is a USA-based biotechnology company. It focuses on the development of regenerative medical applications in the stem cell space. The company's principal products and services include HemaXellarate I, HemaXellerate II, dCell Vax, NR2F6, Tcellvax, identification of Small Molecules, and others. HemaXellarate I and HemaXellerate II are cellular therapies designed to heal damaged bone marrow. dCell Vax is a therapy whereby dendritic cells of the cancer patient are harvested from the body. Tcellvax is an autologous cellular product comprised of NR2F6 gene-silenced peripheral blood mononuclear cells.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 1
Valuation
|
Metric
|
RGBPP
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
RGBPP
|
|---|---|
Quick Ratio | 0.05 |
Current Ratio | 0.05 |
Interest Coverage | −4.63 |
Quick Ratio
RGBPP
Profitability
|
Metric
|
RGBPP
|
|---|---|
Return on Assets (Normalized) | −472.08% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
RGBPP
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|?k@s%Xt | LOCK|$dX@Z | $136B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|pQ@@^$& | LOCK|rrVNf | $84B | |||
| Moderna Inc
MRNA
| LOCK|!zr!?M | LOCK|w%l | $81B | |||
| argenx SE ADR
ARGX
| LOCK|KVx@^DH | LOCK|KC | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|LLhYl@V | LOCK|@# | $44B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|f%tN?%t | LOCK|qyNv | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|<#<>Bdw | LOCK|K@&#% | $28B | |||
| Incyte Corp
INCY
| LOCK|<MmvZ> | LOCK|K? | $24B | |||
| BioNTech SE ADR
BNTX
| LOCK|g#f>Lsf | LOCK|?Y! | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|n@pC<%# | LOCK|$>z | $14B |
United States